NYSE:MCK - McKesson Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $135.45 -0.13 (-0.10 %) (As of 07/17/2018 12:43 PM ET)Previous Close$135.74Today's Range$134.66 - $136.0052-Week Range$131.43 - $178.86Volume16,582 shsAverage Volume1.57 million shsMarket Capitalization$27.56 billionP/E Ratio10.68Dividend Yield1.00%Beta1.29 Company ProfileFinancialsAnalyst RatingsDividend HistoryEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. It also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, the company operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks within North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. Further, it provides software and analytics, network solutions, and technology-enabled services. The company serves retail national accounts, including national and regional chains, food and drug combinations, mail order pharmacies, and mass merchandisers; independent retail pharmacies; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as pharmaceutical manufacturers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California. Receive MCK News and Ratings via Email Sign-up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Drugs, proprietaries, & sundries Sub-IndustryHealth Care Distributors SectorMedical SymbolNYSE:MCK CUSIP58155Q10 Webwww.mckesson.com Phone415-983-8300 Debt Debt-to-Equity Ratio0.67 Current Ratio1.01 Quick Ratio0.57 Price-To-Earnings Trailing P/E Ratio10.68 Forward P/E Ratio10.14 P/E Growth1.27 Sales & Book Value Annual Sales$208.36 billion Price / Sales0.13 Cash Flow$27.9278 per share Price / Cash4.85 Book Value$48.74 per share Price / Book2.78 Profitability EPS (Most Recent Fiscal Year)$12.62 Net Income$67 million Net Margins0.03% Return on Equity23.55% Return on Assets4.23% Miscellaneous Employees78,000 Outstanding Shares201,780,000Market Cap$27,560.58 McKesson (NYSE:MCK) Frequently Asked Questions What is McKesson's stock symbol? McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK." How often does McKesson pay dividends? What is the dividend yield for McKesson? McKesson declared a quarterly dividend on Thursday, April 26th. Investors of record on Friday, June 1st will be given a dividend of $0.34 per share on Monday, July 2nd. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.01%. The ex-dividend date is Thursday, May 31st. View McKesson's Dividend History. How will McKesson's stock buyback program work? McKesson declared that its Board of Directors has approved a share buyback plan on Thursday, October 27th 2016, which allows the company to repurchase $4,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to reacquire up to 114% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's leadership believes its shares are undervalued. How were McKesson's earnings last quarter? McKesson Co. (NYSE:MCK) posted its quarterly earnings results on Thursday, May, 24th. The company reported $3.49 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $3.56 by $0.07. The business had revenue of $51.63 billion for the quarter, compared to analysts' expectations of $51.36 billion. McKesson had a return on equity of 23.55% and a net margin of 0.03%. The company's revenue was up 6.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.41 EPS. View McKesson's Earnings History. When is McKesson's next earnings date? McKesson is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for McKesson. What guidance has McKesson issued on next quarter's earnings? McKesson issued an update on its FY19 earnings guidance on Thursday, June, 28th. The company provided earnings per share (EPS) guidance of $13.00-13.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $13.34. McKesson also updated its Q1 guidance to $2.85-2.95 EPS. What price target have analysts set for MCK? 14 analysts have issued 1 year price targets for McKesson's shares. Their forecasts range from $130.00 to $205.00. On average, they expect McKesson's share price to reach $171.8462 in the next twelve months. This suggests a possible upside of 27.0% from the stock's current price. View Analyst Ratings for McKesson. What is the consensus analysts' recommendation for McKesson? 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 1 sell rating, 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Who are some of McKesson's key competitors? Some companies that are related to McKesson include AmerisourceBergen (ABC), Cardinal Health (CAH), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), Aceto (ACET), biOasis Technologies (BIOAF), Trxade Group (TRXD) and Medizone International (MZEI). Who are McKesson's key executives? McKesson's management team includes the folowing people: Mr. John H. Hammergren, Chairman, CEO & Pres (Age 59)Britt J. Vitalone, CFO & Exec. VP (Age 49)Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 56)Mr. Jorge L. Figueredo, Exec. VP of HR (Age 57)Mr. Paul C. Julian, Exec. VP (Age 63) Has McKesson been receiving favorable news coverage? News stories about MCK stock have trended somewhat positive recently, Accern reports. The research group scores the sentiment of media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. McKesson earned a daily sentiment score of 0.18 on Accern's scale. They also gave media coverage about the company an impact score of 45.36 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days. Who are McKesson's major shareholders? McKesson's stock is owned by a number of of institutional and retail investors. Top institutional investors include Swedbank (0.31%), Hexavest Inc. (0.20%), Bank of Montreal Can (0.09%), Rockland Trust Co. (0.03%), Fjarde AP Fonden Fourth Swedish National Pension Fund (0.03%) and Founders Capital Management LLC (0.03%). Company insiders that own McKesson stock include Erin M Lampert, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Susan R Salka and Wayne A Budd. View Institutional Ownership Trends for McKesson. Which major investors are selling McKesson stock? MCK stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Investment House LLC, Regent Investment Management LLC, Acropolis Investment Management LLC, NN Investment Partners Holdings N.V., Atria Investments LLC, American National Bank and Trust Department MB Financial Bank N A. Company insiders that have sold McKesson company stock in the last year include Erin M Lampert, John H Hammergren, M Christine Jacobs and Marie L/Ca Knowles. View Insider Buying and Selling for McKesson. Which major investors are buying McKesson stock? MCK stock was bought by a variety of institutional investors in the last quarter, including Clinton Group Inc., Founders Capital Management LLC, Swedbank, State of Alaska Department of Revenue, DnB Asset Management AS, IFM Investors Pty Ltd, Campbell & CO Investment Adviser LLC and Rockland Trust Co.. Company insiders that have bought McKesson stock in the last two years include Lori A Schechter and Susan R Salka. View Insider Buying and Selling for McKesson. How do I buy shares of McKesson? Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is McKesson's stock price today? One share of MCK stock can currently be purchased for approximately $135.27. How big of a company is McKesson? McKesson has a market capitalization of $27.56 billion and generates $208.36 billion in revenue each year. The company earns $67 million in net income (profit) each year or $12.62 on an earnings per share basis. McKesson employs 78,000 workers across the globe. How can I contact McKesson? McKesson's mailing address is ONE POST ST, SAN FRANCISCO CA, 94104. The company can be reached via phone at 415-983-8300 or via email at [email protected] MarketBeat Community Rating for McKesson (NYSE MCK)Community Ranking: 3.3 out of 5 ( )Outperform Votes: 729 (Vote Outperform)Underperform Votes: 373 (Vote Underperform)Total Votes: 1,102MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote "Outperform" if you believe MCK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCK will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/17/2018 by MarketBeat.com StaffFeatured Article: What does earnings per share mean?